{"id":"https://openalex.org/W7225433566","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","title":"1187 Safety and efficacy of cesalatamig, a novel PD-1/VEGF bispecific antibody, as monotherapy in PD-(L)1\u2013resistant/refractory NSCLC: Results from global, multicenter, open-label phase 1/2 studies","display_name":"1187 Safety and efficacy of cesalatamig, a novel PD-1/VEGF bispecific antibody, as monotherapy in PD-(L)1\u2013resistant/refractory NSCLC: Results from global, multicenter, open-label phase 1/2 studies","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225433566","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1187"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1187","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","pdf_url":"https://jitc.bmj.com/content/14/Suppl_3/A1403.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-Breaking Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_3/A1403.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075792907","display_name":"Kai He","orcid":"https://orcid.org/0000-0002-4378-9297","observed_orcids":["https://orcid.org/0000-0002-4378-9297"]},"institutions":[{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kai He","raw_affiliation_strings":["R & G Pharma US, Inc., Somerset, NJ, USA","University of Texas Mays Cancer Center at San Antonio, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R & G Pharma US, Inc., Somerset, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"University of Texas Mays Cancer Center at San Antonio, San Antonio, TX, USA","institution_ids":["https://openalex.org/I4390039360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161055070","display_name":"Jin-ji Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153930","display_name":"Guangdong Provincial People's Hospital","ror":"https://ror.org/045kpgw45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jin-ji Yang","raw_affiliation_strings":["Guangdong Lung Cancer Institute, Guangdong Provincial People\u2019s Hospital, Guangzhou, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong Lung Cancer Institute, Guangdong Provincial People\u2019s Hospital, Guangzhou, Guangdong, China","institution_ids":["https://openalex.org/I4210153930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048259248","display_name":"Mingjia Li","orcid":"https://orcid.org/0000-0002-3910-4179","observed_orcids":["https://orcid.org/0000-0002-3910-4179"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingjia Li","raw_affiliation_strings":["The Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073920457","display_name":"Maya Khalil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maya Khalil","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043773782","display_name":"Vaia Florou","orcid":"https://orcid.org/0000-0001-5558-753X","observed_orcids":["https://orcid.org/0000-0001-5558-753X"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaia Florou","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161066012","display_name":"Matthrew Gumbleton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthrew Gumbleton","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034030001","display_name":"Bin Yang","orcid":"https://orcid.org/0000-0002-6218-2773","observed_orcids":["https://orcid.org/0000-0002-6218-2773"]},"institutions":[{"id":"https://openalex.org/I4210160841","display_name":"Hubei Cancer Hospital","ror":"https://ror.org/05p38yh32","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210160841"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bin Yang","raw_affiliation_strings":["Hubei Cancer Hospital, Wuhan, NA, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hubei Cancer Hospital, Wuhan, NA, China","institution_ids":["https://openalex.org/I4210160841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161098002","display_name":"Zhi-hua Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097309","display_name":"Jiangxi Provincial Cancer Hospital","ror":"https://ror.org/00v8g0168","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210097309"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhi-hua Liu","raw_affiliation_strings":["Jiangxi Cancer Hospital, Nanchang, Jiangxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangxi Cancer Hospital, Nanchang, Jiangxi, China","institution_ids":["https://openalex.org/I4210097309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012572593","display_name":"Luis Estuardo Raez","orcid":"https://orcid.org/0000-0003-2669-5771","observed_orcids":["https://orcid.org/0000-0003-2669-5771"]},"institutions":[{"id":"https://openalex.org/I4210098576","display_name":"Memorial Healthcare System","ror":"https://ror.org/016d4cn96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098576"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luis Raez","raw_affiliation_strings":["Memorial Health System, Pembroke Pines, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Health System, Pembroke Pines, FL, USA","institution_ids":["https://openalex.org/I4210098576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109504564","display_name":"Eric Scott Schaefer","orcid":"https://orcid.org/0009-0007-4929-6454","observed_orcids":["https://orcid.org/0009-0007-4929-6454"]},"institutions":[{"id":"https://openalex.org/I4210107699","display_name":"Highlands Oncology Group","ror":"https://ror.org/01k1j7593","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107699"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Schaefer","raw_affiliation_strings":["Highlands Oncology, Fayetteville, AR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Highlands Oncology, Fayetteville, AR, USA","institution_ids":["https://openalex.org/I4210107699"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090712976","display_name":"Cameron M. Pywell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802152183","display_name":"Novant Health","ror":"https://ror.org/04nv2wh79","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cameron Pywell","raw_affiliation_strings":["Novant Health, Winston Salem, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novant Health, Winston Salem, NC, USA","institution_ids":["https://openalex.org/I2802152183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040159842","display_name":"Joshua E. Reuss","orcid":"https://orcid.org/0000-0002-6401-9080","observed_orcids":["https://orcid.org/0000-0002-6401-9080"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Reuss","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161086963","display_name":"Yu Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Liu","raw_affiliation_strings":["Neijiang Second People\u2019s Hospital, NeiJiang, Sichuan, China","OncoC4, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neijiang Second People\u2019s Hospital, NeiJiang, Sichuan, China","institution_ids":[]},{"raw_affiliation_string":"OncoC4, Inc., Rockville, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159616512","display_name":"John Hamm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202709704","display_name":"Norton Healthcare","ror":"https://ror.org/0266h1q26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I202709704"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Hamm","raw_affiliation_strings":["Norton Cancer Institute, Louisville, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norton Cancer Institute, Louisville, KY, USA","institution_ids":["https://openalex.org/I202709704"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101704338","display_name":"Qitao Yu","orcid":"https://orcid.org/0000-0003-1376-6649","observed_orcids":["https://orcid.org/0000-0003-1376-6649","https://orcid.org/0000-0003-3504-3724"]},"institutions":[{"id":"https://openalex.org/I160354086","display_name":"Guangxi Medical University","ror":"https://ror.org/03dveyr97","country_code":"CN","type":"education","lineage":["https://openalex.org/I160354086"]},{"id":"https://openalex.org/I4210155683","display_name":"Tumor Hospital of Guangxi Medical University","ror":"https://ror.org/051mn8706","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210155683"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qitao Yu","raw_affiliation_strings":["Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China","institution_ids":["https://openalex.org/I160354086","https://openalex.org/I4210155683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161113839","display_name":"Huilin Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I160354086","display_name":"Guangxi Medical University","ror":"https://ror.org/03dveyr97","country_code":"CN","type":"education","lineage":["https://openalex.org/I160354086"]},{"id":"https://openalex.org/I4210155683","display_name":"Tumor Hospital of Guangxi Medical University","ror":"https://ror.org/051mn8706","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210155683"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huilin Wang","raw_affiliation_strings":["Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China","institution_ids":["https://openalex.org/I160354086","https://openalex.org/I4210155683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052069729","display_name":"Guru Sonpavde","orcid":"https://orcid.org/0000-0002-1010-9611","observed_orcids":["https://orcid.org/0000-0002-1010-9611"]},"institutions":[{"id":"https://openalex.org/I4405270336","display_name":"AdventHealth","ror":"https://ror.org/00gqase94","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405270336"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guru P Sonpavde","raw_affiliation_strings":["Advent Health Cancer Institute, Orlando, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advent Health Cancer Institute, Orlando, FL, USA","institution_ids":["https://openalex.org/I4405270336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111567764","display_name":"Tarek M. Mekhail","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270336","display_name":"AdventHealth","ror":"https://ror.org/00gqase94","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405270336"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarek Mekhail","raw_affiliation_strings":["Advent Health Cancer Institute, Orlando, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advent Health Cancer Institute, Orlando, FL, USA","institution_ids":["https://openalex.org/I4405270336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060793722","display_name":"St\u00e9phane Champiat","orcid":"https://orcid.org/0000-0002-0741-2118","observed_orcids":["https://orcid.org/0000-0002-0741-2118"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephane Champiat","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004814161","display_name":"Devalingam Mahalingam","orcid":"https://orcid.org/0000-0002-2979-9894","observed_orcids":["https://orcid.org/0000-0002-2979-9894"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devalingam Mahalingam","raw_affiliation_strings":["Northwestern University Medical Center, Evanston, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University Medical Center, Evanston, IL, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019054264","display_name":"Bilal Anouti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bilal Anouti","raw_affiliation_strings":["Northwestern University Medical Center, Evanston, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University Medical Center, Evanston, IL, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161063099","display_name":"Yongsheng Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I158842170","display_name":"Chongqing University","ror":"https://ror.org/023rhb549","country_code":"CN","type":"education","lineage":["https://openalex.org/I158842170"]},{"id":"https://openalex.org/I4210154480","display_name":"Chongqing Cancer Hospital","ror":"https://ror.org/047d8yx24","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154480"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yongsheng Li","raw_affiliation_strings":["Chongqing University Cancer Hospital, Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chongqing University Cancer Hospital, Chongqing, China","institution_ids":["https://openalex.org/I158842170","https://openalex.org/I4210154480"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161000740","display_name":"Meili Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106451","display_name":"Jinan Central Hospital","ror":"https://ror.org/01fr19c68","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106451"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Meili Sun","raw_affiliation_strings":["Jinan Central Hospital, Jinan, Shandong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jinan Central Hospital, Jinan, Shandong, China","institution_ids":["https://openalex.org/I4210106451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055799241","display_name":"Qing Wen","orcid":"https://orcid.org/0000-0002-6408-2370","observed_orcids":["https://orcid.org/0000-0002-6408-2370"]},"institutions":[{"id":"https://openalex.org/I4210106451","display_name":"Jinan Central Hospital","ror":"https://ror.org/01fr19c68","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210106451"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qing Wen","raw_affiliation_strings":["Jinan Central Hospital, Jinan, Shandong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jinan Central Hospital, Jinan, Shandong, China","institution_ids":["https://openalex.org/I4210106451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020154592","display_name":"Thomas J. George","orcid":"https://orcid.org/0000-0002-6249-9180","observed_orcids":["https://orcid.org/0000-0002-6249-9180"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J George","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073462876","display_name":"Aline Fusco Fares","orcid":"https://orcid.org/0000-0002-7730-9810","observed_orcids":["https://orcid.org/0000-0002-7730-9810"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aline Fares","raw_affiliation_strings":["University of Florida, Gainesville, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida, Gainesville, FL, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006262746","display_name":"Fawzi Abu Rous","orcid":"https://orcid.org/0000-0002-7458-9802","observed_orcids":["https://orcid.org/0000-0002-7458-9802"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fawzi Abu Rous","raw_affiliation_strings":["Henry Ford Health, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health, Detroit, MI, USA","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159937476","display_name":"Georgios Fotopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Georgios Fotopoulos","raw_affiliation_strings":["University of Texas Mays Cancer Center at San Antonio, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Mays Cancer Center at San Antonio, San Antonio, TX, USA","institution_ids":["https://openalex.org/I4390039360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130817112","display_name":"Shiling Song","orcid":"https://orcid.org/0009-0009-7126-4875","observed_orcids":["https://orcid.org/0009-0009-7126-4875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiling Song","raw_affiliation_strings":["OncoC4, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoC4, Inc., Rockville, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073695473","display_name":"Kazuharu Kai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuharu Kai","raw_affiliation_strings":["OncoC4, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoC4, Inc., Rockville, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140609031","display_name":"Kun He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kun He","raw_affiliation_strings":["R & G Pharma US, Inc., Somerset, NJ, USA","University of Texas Mays Cancer Center at San Antonio, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R & G Pharma US, Inc., Somerset, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"University of Texas Mays Cancer Center at San Antonio, San Antonio, TX, USA","institution_ids":["https://openalex.org/I4390039360"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161045023","display_name":"Yang Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["Neijiang Second People\u2019s Hospital, NeiJiang, Sichuan, China","OncoC4, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neijiang Second People\u2019s Hospital, NeiJiang, Sichuan, China","institution_ids":[]},{"raw_affiliation_string":"OncoC4, Inc., Rockville, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161129877","display_name":"Pan Zheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pan Zheng","raw_affiliation_strings":["OncoC4, Inc., Rockville, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoC4, Inc., Rockville, MD, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160902171","display_name":"Yi-Long Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153930","display_name":"Guangdong Provincial People's Hospital","ror":"https://ror.org/045kpgw45","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi-Long Wu","raw_affiliation_strings":["Guangdong Lung Cancer Institute, Guangdong Provincial People\u2019s Hospital, Guangzhou, Guangdong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangdong Lung Cancer Institute, Guangdong Provincial People\u2019s Hospital, Guangzhou, Guangdong, China","institution_ids":["https://openalex.org/I4210153930"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":22,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1403","last_page":"A1404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.41200000047683716},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7523000240325928},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42820000648498535},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41029998660087585},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4065999984741211},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3880000114440918},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3465999960899353},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.3443000018596649},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.31150001287460327},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.3001999855041504},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2694999873638153},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.25589999556541443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.1187","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","pdf_url":"https://jitc.bmj.com/content/14/Suppl_3/A1403.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-Breaking Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1187","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1187","pdf_url":"https://jitc.bmj.com/content/14/Suppl_3/A1403.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-Breaking Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225433566.pdf","grobid_xml":"https://content.openalex.org/works/W7225433566.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7225423430","https://openalex.org/W4415942749","https://openalex.org/W4403420048","https://openalex.org/W7196963648","https://openalex.org/W4415871442","https://openalex.org/W4387810598","https://openalex.org/W4281799849","https://openalex.org/W4415519590","https://openalex.org/W4310924692","https://openalex.org/W7162549431"],"abstract_inverted_index":{"Background":[0],"Patients":[1,323],"with":[2,24,39,86,107,184,186,193,324,362,369,435,506],"anti-PD-(L)1-resistant/refractory":[3],"(R/R)":[4],"non-small":[5],"cell":[6],"lung":[7],"cancer":[8],"(NSCLC)":[9],"have":[10,152],"limited":[11],"treatment":[12],"options":[13],"other":[14],"than":[15,30],"chemotherapy.":[16],"Cesalatamig":[17,55,353],"is":[18,376],"a":[19,33,40,49,102,206,348,363],"novel":[20],"PD-1/VEGF":[21,391],"bispecific":[22],"antibody":[23],"40-fold":[25],"higher":[26],"affinity":[27],"for":[28,347],"VEGF":[29],"bevacizumab.":[31],"As":[32,144],"result,":[34],"cesalatamig":[35,82,127,330,507],"showed":[36],"best-in-class":[37],"potential":[38],"differentiated":[41],"cooperative":[42],"interaction":[43],"that":[44,385],"favor":[45],"its":[46],"action":[47],"in":[48,83,140,247,256,263,351,367,393,433,449,456,475,491],"PD-1":[50,67],"and":[51,78,111,133,137,173,190,195,237,265,294,300,311,320,357,404,411,428,452,471,478,487,516],"VEGF-rich":[52],"tumor":[53,158],"microenvironment.":[54],"also":[56],"has":[57],"more":[58],"effective":[59],"Fc-silencing":[60],"modifications":[61],"to":[62,125,329,400],"avoid":[63],"the":[64,75,89,141,286,315,345,377,402,407,436,450,476],"depletion":[65],"of":[66,81,104,120,145,203,210,215,218,224,234,258,303,333,340,380,497,512],"positive":[68],"effector":[69],"T":[70],"cells.":[71],"Here":[72],"we":[73],"report":[74,379],"preliminary":[76],"safety":[77,142,179,261,365,517],"clinical":[79],"activity":[80,164,361],"pretreated":[84],"patients":[85,106,151,183,204,225,289,296,368,403],"NSCLC":[87,108,325,504],"from":[88,109,431],"global":[90,381],"Phase":[91,99,382],"1/2":[92,100],"studies.Methods":[93],"In":[94],"these":[95],"global,":[96],"multicenter,":[97],"open-label":[98],"studies,":[101],"total":[103],"103":[105,182],"US":[110],"China,":[112],"who":[113],"experienced":[114],"disease":[115,174,327],"progression":[116],"after":[117],"\u22651":[118],"line":[119],"systemic":[121],"therapy":[122,219],"were":[123,138,245,254],"enrolled":[124],"receive":[126],"monotherapy":[128,331,354],"at":[129,154,413],"1,":[130,298],"3,":[131],"10":[132,301,341],"20":[134],"mg/kg,":[135],"Q3W,":[136],"included":[139,181],"population.":[143],"July":[146],"31,":[147],"2026,":[148],"55":[149,287],"anti-PD(L)1-R/R":[150],"received":[153,227,297],"least":[155],"one":[156,196],"post-baseline":[157],"assessment":[159],"per":[160],"RECIST":[161],"1.1.":[162],"Clinical":[163],"was":[165,220,268,276,283,308,317,420],"evaluated":[166],"by":[167,422],"investigator-determined":[168],"objective":[169],"response":[170,328],"rate":[171,176],"(ORR)":[172],"control":[175],"(DCR).Results":[177],"The":[178,212,260,270,306,396,442,459],"population":[180],"NSCLC,":[185],"77":[187],"(75%)":[188],"non-squamous":[189,266],"25":[191],"(24%)":[192],"squamous":[194,264],"unknown":[197],"histology":[198,267],"(":[199],"table":[200],"1).":[201],"77%":[202],"had":[205,226],"baseline":[207],"ECOG":[208],"score":[209],"1.":[211],"median":[213],"number":[214],"prior":[216,229,498],"lines":[217],"2,":[221],"while":[222,249,314],"42%":[223],"3+":[228],"lines,":[230],"including":[231],"both":[232],"standard":[233],"care":[235],"chemotherapies":[236],"immunotherapies.":[238],"Grade":[239,273],"3-4":[240,274],"treatment-related":[241,250],"adverse":[242,252],"events":[243,253],"(TRAEs)":[244],"seen":[246],"18%,":[248],"serious":[251],"observed":[255],"11%":[257],"patients.":[259],"profile":[262,366],"comparable.":[269],"most":[271],"common":[272],"TRAE":[275],"hypertension":[277],"(10%).":[278],"Treatment":[279],"related":[280],"drug":[281],"discontinuation":[282],"1%.":[284],"Of":[285],"evaluable":[288],"(figure":[290],"1),":[291],"10,":[292],"24":[293],"21":[295],"3":[299],"mg/kg":[302,342],"cesalatamig,":[304],"respectively.":[305,322],"ORR":[307],"10%,":[309],"21%,":[310],"33%,":[312],"respectively,":[313],"DCR":[316],"40%,":[318],"67%,":[319],"90%,":[321],"demonstrated":[326,355],"regardless":[332],"PD-L1":[334],"level.":[335],"Exposure-response":[336],"analyses":[337],"support":[338,386],"selection":[339],"Q3W":[343],"as":[344,447,454,473,489],"dose":[346],"pivotal":[349,387],"study":[350],"planning.Conclusions":[352],"robust":[356],"clinically":[358],"meaningful":[359],"antitumor":[360],"manageable":[364],"PD-(L)1-R/R":[370],"NSCLC.":[371],"To":[372],"our":[373],"knowledge":[374],"this":[375,394],"first":[378],"2":[383],"results":[384,518],"trial":[388],"using":[389],"dual":[390],"blockade":[392],"indication.Acknowledgements":[395],"authors":[397],"would":[398],"like":[399],"thank":[401],"their":[405],"families/caregivers,":[406],"staff,":[408],"research":[409],"coordinators,":[410],"investigators":[412],"each":[414],"participating":[415],"institution.":[416],"Medical":[417],"writing":[418],"assistance":[419],"provided":[421],"Drs.":[423],"Chris":[424],"Leung,":[425],"Juan":[426],"Su,":[427],"David":[429],"Cerna":[430],"OncoC4":[432],"accordance":[434],"Good":[437],"Publication":[438],"Practice":[439],"guidelines.Trial":[440],"Registration":[441],"BiPAVE-001":[443,460],"trials":[444,461],"are":[445,462],"registered":[446,453,472,488],"NCT06635785":[448,474],"U.S.":[451],"CTR20253261":[455,490],"China.Ethics":[457],"Approval":[458],"being":[463],"conducted":[464],"under":[465,479],"WCG":[466],"IRB":[467],"Study":[468],"Number":[469,485],"20244932":[470],"U.S.,":[477],"Guangdong":[480],"Provincial":[481],"People\u2019s":[482],"Hospital\u2019s":[483],"EC":[484],"YW2025-087":[486],"China.Abstract":[492],"1187":[493,509],"Figure":[494],"1Waterfall":[495],"plot":[496],"PD-(L)1":[499],"inhibitor":[500],"experienced,":[501],"AGA":[502],"negative":[503],"treated":[505],"Q3WAbstract":[508],"Table":[510],"1Summary":[511],"demographics,":[513],"patient":[514],"characteristic":[515]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}